#financialresults

Ahead of next week’s board meeting let’s revisit the 1 year returns for PSX and their peers:

PSX: +108%
VLO: +150%
MPC: +166%
PBF: +209%

Any insight into how Q3 has gone? Sensible, factual answers please (not the normal it’s all going downhill responses and rants)

Lowering personnel expenses has directly increases BNY's operating margin. Corporate severance expenses shrunk significantly from $240 million in 2024 down to $18 million in Q1 2026 and $6 million in Q2 2026. This aggressive reduction in internal structural overhead has cushioned net income even as active client transactions continue to stall.

Has anyone noticed that in the last one month - BNY has dropped 10% and they have not even announced earnings YET.

Add to this, the write offs and losses stemming from Wove disaster and the big spend that is being proposed for revamping the platform with additional AI spend.

Where will BNY land ?

Wonder what will happen to make the 3Q 2026 reporting for the shareholders more palatable?

So what we generated more cash than others. This is a meaningless comparison when we are a much bigger company than them. Use a meaningful metric. Show ROCE over time vs competitors. Something that normalizes the performance.

CDW reported Q2 2026 net income of $274 million, while carrying a substantial debt load of $5.82 billion. Areas to watch: leverage, cash & credit rating. CDW's debt increase continues to balloon, with cash flow dropping from $443M to $220M.

If the number doesn't look good, here is the upside. Disappointing Q3 will guarantee RA for Arvind and much of the executives.

Street is predicting Centene to make 70B with a huge B and yet, we have senior leadership team laying off people.

• Wells Fargo & Co. Chief Financial Officer Michael Santomassimo said that the lender’s net interest margin is expected to be better than initially expected.

Coming into the quarter, Santomassimo said executives thought the margin would be down three or four basis points. Now, the measure is likely to be down one basis point or potentially even flat, he said Tuesday at a Barclays Plc conference.*

https://www.bloomberg.com/news/articles/2026-09-15/wells-fargo-cfo-points-to-better-than-expected-interest-margin

... but we will still ✂️ people to improve our efficiency ratio. The target is below 60% for the full year.

RSU value in red by 45%

The title says it all.

reposting this question because the last one got hijacked with absolute nonsense replies.

We're down to three and a half months left in this year. Dan promised Wall St five billion dollars in savings this year. I don't think the 13k people laid off last year even counts toward number. Anybody here smart enough to figure where we are towards the five billion number, and how we will get the rest of the way there by year's end?

With the stock price plummeting back to all time lows, will there be additional layoffs to cut expenses?

I would like to congratulate the PEP team for this outstanding achievement. This is truly a testament to your dedication, leadership and passion for winning ! Not every organization with a Market Cap of $194B and 300,000 employees worldwide is capable of providing a lower rate of return to its investors than a Money Market fund. Although this may not create smiles for our investors, who cares, it's important to remember that change is difficult and just achieving this small positive number is something you can all be proud of. Let's try for +1.04 in the last 4 months of 2026 !

Nike went from “Just Do It” to “Just Blew It.” The stock fell from its record closing high of $177.51 in November 2021 to $39.48 on August 25, 2026—a nearly 78% decline. The Swoosh has become a downhill chart. 📈

Eli Lilly achieved significant revenue growth in Q2 2026, boosted by strong sales of its obesity medications. In contrast, Novo Nordisk faced challenges including price reductions and workforce reductions. Lilly is expanding its dr-g pipeline and has increased its financial outlook for the year. Novo Nordisk is working to stabilize its operations amidst pricing pressures. The upcoming year will be crucial for both companies as they navigate dr-g approvals and market strategies.

New York, New York

https://pluang.com/en/news-feed/eli-lilly-vs-novo-nordisk-pemenang-dalam-perlombaan-obat-penurun-berat-badan

Does anyone else have a problem buying the absolute BS that comes with these recent townhalls? Trying to oversell the progress of the company even among the financial losses, low clinician satisfaction and lack of moral within employees? They keep preaching that they are listening to grievances, yet they continue pushing next agendas and plans for changes when we aren’t stable enough to implement successfully. Saying they want more automation = less need for manpower = layoffs. But they don’t say it.

The latest earnings call and filings are worrying. I read somewhere that $1m per day is going towards interest payments? Can we expect even more layoffs?

Baron's magazine stopped just short of calling Honeywell Aero stock a value trap today: "Put together, we see Honeywell’s growth continuing to lag its peers. While the valuation is relatively inexpensive, we fear that this could be a value trap." It's no longer Honeywell, but it kept the name and the worst parts of the business practices and senior management hubris. Time to clean house in the executive suite completely and get rid of the old Allied Signal and Jack Welsh disciples that do nothing but poison companies , set them up to fail, and then walk off with golden parachutes. The downtime from the IT migration alone was in the tens of millions of dollars in Q1 alone. The migration residual issues are still a huge and expensive problem that prevents people from doing their work. It's turned into it's own whack-a-mole-zombie-juggernaut nightmare. Run, do not walk, away from this stock until they purge the cancer at the top and show solid financial results.

Why was the Townhall canceled? There are several rumors about why they keep canceling the TH (3 times since June). they are cooking something up. A potential IPO? Maybe not. Poor Q2 numbers? What else?

https://www.thelayoff.com/post/@OP+1ky077cr1

Ugly drop today.
Don’t say you weren’t warned.
Called the drop to 160 …. 24 days ago on the Honeywell international layoff forum.
Welcome to fair value.
Another miss and we test 120’s.

What part of the quarter can be described as "great"?

Q2 was apparently a great quarter for the company. Great enough to raise the yearly outlook. Leadership made sure to credit us for it.

Remember when the raise was contingent on a good Q2? Yeah. Turns out the goalposts have wheels. Other regions got bumps in Q1. We got a pat on the back and a rerun of 2024's paycheck.

Meanwhile the CEO's total comp for the year lands north of $3.9M. Must be a real coincidence that number moves easier than ours does.

Why does this matter? Because Nike needs to be prepared for a financial downturn. With the consumer already struggling with high gas prices and consumer goods, Nike will be forced to make short term decisions. These short term decisions will hope to buoy the stock price just enough to prevent further bleeding.

What does that mean for all of us? More severe layoffs. Not just Nike but every company that lacks the financials to survive. Won't be '08 all over again, but it won't feel good.

Thinking this explains everything if your willing to consider context today. .

Non-Proforma Market Capitalization Pre-Merger Market Cap (Dec 2019)

BB&T $41.60 Billion
SunTrust $31.10 Billion
Combined Independent Baseline $72.70 Billion

August 2026 Truist Financial Corp. (TFC)—$63.33 Billion

This represents a net equity destruction of 12.89% of the original standalone value and provides some situational awareness.

Billy R. and B' monkey Cummings just bought a pottery wheel and kiln to make designer coffee cups for Mike Mayo and all the other shareholders and employees that have lost money.

Uptick in demand boosts Ruger to $7 million in net income after 90 layoffs in Newport

https://www.unionleader.com/news/business/uptick-in-demand-boosts-ruger-to-7-million-in-net-income-after-90-layoffs-in/article_bb92434d-965e-4975-b1f2-49e9154bf38d.amp.html

More revenue declines, Ai talk when will it generate revenue???
But the company is very profitable making 685million. More bullsh-t about cost takeout in GIS. Usual b4llsheet.

IBM attributed part of its weak quarter to customers redirecting budgets toward servers, storage and memory amid supply constraints and expected price increases.

Microsoft faced the same component pressures—and much greater exposure to AI infrastructure costs—yet reported:

• 18% revenue growth
• 43% Azure growth
• 18% operating-income growth
• $59.3 billion in Microsoft Cloud revenue
• $41 billion of quarterly capital investment

IBM, by comparison, reported:

• 1% total revenue growth
• 5% software growth
• 7% infrastructure decline
• A reduced 4%–5% constant-currency growth outlook

This does not prove IBM customers experienced no budget pressure. It does suggest that memory shortages alone are an incomplete explanation.

Microsoft is absorbing higher infrastructure costs because customers are prioritizing its cloud and AI platforms. IBM appears to be losing spending because customers are prioritizing those platforms instead of IBM’s mainframes and traditional software.

That points less to a temporary supply-chain issue and more to a competitive-positioning problem.

[Microsoft results]
(https://www.microsoft.com/en-us/investor/earnings/fy-2026-q4/press-release-webcast) [IBM investor letter]
(https://newsroom.ibm.com/2026-07-14-Arvind-Krishnas-Letter-to-IBM-Investors) | [Yahoo Finance analysis]
(https://finance.yahoo.com/markets/article/microsofts-41-billion-ai-bet-just-cleared-a-major-test-chart-of-the-day-100000116.html)

Great to see all the initiatives and strategies correlate into strong earnings.

Lead to One should continue to drive meaningful value and strong financial results.

Patient Care Solutions saw a YOY change of -13.3% and a net loss of 26 Million (EIBT). GE Healthcare is officially reviewing all strategic options

Centene stock (NYSE: CNC) fell nearly 9% following its Q2 2026 earnings report because projected headwinds and higher attrition in its Medicaid business overshadowed an otherwise strong profit and revenue beat.

ST. LOUIS, July 28, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC) (the Company) announced today its financial results for the second quarter ended June 30, 2026. In summary, the 2026 second quarter results were as follows:

Total revenues (in millions) $53,579
Premium and service revenues (in millions)
$44,375
Health benefits ratio 89.6 %
SG&A expense ratio 7.0 %
Adjusted SG&A expense ratio (1) 6.9 %
GAAP diluted earnings per share $2.19
Adjusted diluted earnings per share (1) $2.51
Total cash flow provided by operations (in millions) $3,590